Furthermore, treatment with LDN-193189, noggin and ALK3-Fc (BMP antagonists) can inhibit IL-6-induced hepcidin expression, leading to improved turpentine-induced anemia [48]. Here, BMPR1A is linked to anemia (phenotype).